Common Digestive Drug May Help Ease Depression and Brain Fog

Scientists in England have found that a drug used to treat constipation might also help people who struggle with memory and focus after depression. Researchers at the University of Birmingham and the University of Oxford ran a small study with 50 adults. The results showed that people who took the drug did better on memory and thinking tests than those who did not. The findings were published in a journal called Psychological Medicine.

Many people recover from depression but still deal with problems like poor memory, trouble focusing, and mental fog. Doctors call this 'brain fog,' even though it is not an official medical term. It can make everyday tasks feel much harder than they used to be. People may forget appointments, lose track of conversations, or struggle to make simple decisions. These problems can affect work, relationships, and daily life long after depression has faded.

The drug at the center of the study is called prucalopride. It is already approved by doctors to treat chronic constipation, which means ongoing difficulty with bowel movements. The drug works by activating a special receptor in the body called 5-HT4. This receptor is found in both the gut and the brain. Since the brain chemical serotonin plays a role in both digestion and thinking, scientists wondered if the drug could improve mental performance too.

In the study, 50 adults who had recovered from depression at least six months before took part. None of them were taking any medication at the time. Half of the group took the standard dose of prucalopride each day, and the other half took a placebo, which is a pill with no active medicine. They did this for seven to ten days. Before and after, they completed tests that measured memory, attention, and how fast they could process information.

The results were encouraging. People who took prucalopride answered questions faster and more accurately than those who took the placebo. The researchers found improvements in both short-term and long-term memory, as well as attention and processing speed. Importantly, no serious side effects were reported during the study. Participants did not have major gut-related complaints either.

Experts are being careful not to get too excited too soon. Dr. Bradley Powell, a clinical psychologist who was not part of the study, said the results are a promising early sign but should not be seen as proof of a ready treatment. He pointed out that the group studied was small and fairly specific. For example, the study did not include people who are currently depressed, older adults, or people taking antidepressants. More research is needed before doctors could recommend this drug for brain fog.

The research team agrees that larger studies are the next step. Dr. Angharad de Cates, who led the study, said the findings offer real hope for people dealing with thinking problems tied to depression. However, she made it clear that it is too early for people to start using prucalopride on their own for this purpose. Dedicated clinical trials are needed before it could become an approved treatment. The team plans to keep studying medications that target the 5-HT4 receptor, which may offer broader mental health benefits in the future.